Georgia State University
Atlanta, Georgia, 30302, United States
NCT Number: NCT05996718
The goals of this clinical trial are to: 1) refine the training program, "Improving Care though Improv;" and 2) test the program for its influence self-perceived caregiving mastery (i.e., how persons assess their ability to provide care) among informal caregivers of persons living with moderate dementia. Forty-three informal caregivers will be involved in testing the training program. These individuals will be assigned to groups of between 8 to12 caregivers and take part in weekly 2-hour sessions held over a 4-week period. These caregivers will be taught improvisational (improv) theater skills, which involves being in the moment, self-awareness, and responsiveness to others. This group also will be asked to answer surveys questions about themselves and the person receiving care at three timepoints and invited to provide feedback on their training experiences.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Atlanta, Georgia, 30302, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Potential participants were excluded if they did not meet the above criteria or anticipated moving their person to a skilled nursing facility within the next 6 months.
This intervention for informal caregivers consists of training that will introduce participants to improvisational (improv) theatre and teach its core communication skills.
Time frame: at baseline, upon training completion (Week 4), and three months post baseline.
4-item Likert-type scale; scores range from 4 to 16 with higher scores indicating greater feelings of competence.
Time frame: at baseline, upon training completion (Week 4), and three months post baseline.
14-item Likert-type scale. Scores range from 0 to 56 with higher scores indicating greater stress.
Time frame: at baseline, upon training completion (Week 4), and three months post baseline.
20-item Likert-type scale. Scores range from 0 to 60 with higher scores indicating greater depression.
Time frame: at baseline, upon training completion (Week 4), and three months post baseline.
20-item Likert-type scale. Scores range from 20 to 80 with higher scores indicating greater anxiety.
Time frame: at baseline, upon training completion (Week 4), and three months post baseline.
22-item scale with 4-point Likert scale responses. Scores range from 0 to 88 with higher scores indicating greater burden.
Time frame: at baseline, upon training completion (Week 4), and three months post baseline.
24-item scale with 4-point Likert scale responses. Scores range from 0 to 96 with higher scores indicating greater behavioral expressions observed by caregivers among persons living with dementia.
Time frame: at baseline, upon training completion (Week 4), and three months post baseline.
13 items with a 4-point Likert scale. Scores range from 13 to with 52 with higher scores indicating greater quality of life among persons living with dementia
Time frame: at baseline, upon training completion (Week 4), and three months post baseline.
24-item scale with 4-point Likert scale responses. Scores range from 0 to 96 with higher scores indicating greater behavioral expressions observed by caregivers among persons living with dementia.
Georgia State University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07680062
Behavior, Behavioral Symptoms
Istanbul, Uskudar, Turkey (Türkiye)
View Trial DetailsNCT07643714
Behavior, Behavioral Symptoms
Kahramanmaraş, Turkey (Türkiye)
View Trial DetailsNCT05527405
Alzheimer Disease, Assistive Technology
Atlanta, Georgia, United States
View Trial DetailsNCT05992467
Behavior, Behavioral Symptoms
Fairfax, Virginia, United States
View Trial Details